Key result
Select ABCA1 variants associate with ApoA1 levels and myocardial infarction risk, without haplotype effects.
Observational
Answers are grounded in this paper and cite their sources.
OBJECTIVE: By regulating the cellular cholesterol efflux from peripheral cells to high-density lipoprotein, the ABCA1 protein is suspected to play a key role in lipid homeostasis and atherosclerosis. Twenty-six polymorphisms of the ABCA1 gene were genotyped and tested for association with plasma levels of ApoA1 and myocardial infarction (MI) in the ECTIM study. METHODS AND RESULTS: In addition to single-locus analysis, a systematic exploration of all possible haplotype effects was performed, with this exploration being performed on a minimal set of "tag" polymorphisms that define the haplotype structure of the gene. Two polymorphisms were associated with plasma levels of ApoA1, 1 in the promoter (C-564T) and 1 in the coding (R1587K) regions, whereas only 1 polymorphism (R219K) was associated with the risk of MI. However, no haplotype effect was detected on ApoA1 variability or on the risk of MI. CONCLUSIONS: ABCA1 gene polymorphisms but not haplotypes are involved in the variability of plasma ApoA1 and the susceptibility to coronary artery disease.
No takes yet. Share an insight, caveat, or question.
Trégouët et al. (2004) conducted an observational in Myocardial infarction and coronary artery disease. ABCA1 gene polymorphisms and haplotypes (including C-564T, R1587K, and R219K) vs. Alternative genotypes/haplotypes was evaluated on Plasma levels of ApoA1 and risk of myocardial infarction. Out of 26 ABCA1 polymorphisms, 2 (C-564T, R1587K) were associated with plasma ApoA1 levels and 1 (R219K) with myocardial infarction risk, with 0 haplotype effects detected.
Synapse has enriched 10 related papers. Consider them for comparative context: